BIOGEN INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
BIOGEN INC. (BIIB) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $2.52 billion for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-04-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-04-24
- BIOGEN INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $2.52B, a 6.02% increase year-over-year.
- BIOGEN INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $2.71B, a 8.37% increase year-over-year.
- BIOGEN INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $2.62B, a 3.26% increase year-over-year.
- BIOGEN INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $2.64B, a 7.04% increase year-over-year.
- BIOGEN INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $10.35B, a 5.47% increase from fiscal 2016.
- BIOGEN INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $9.82B, a 6.85% increase from fiscal 2015.
- BIOGEN INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $9.19B, a 12.01% increase from fiscal 2014.
- BIOGEN INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $8.20B, a 48.01% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $2.52B 10-Q · filed 2018-04-24 | $5.24B derived: sum of 2 quarters · filed 2018-04-24 | $7.86B derived: sum of 3 quarters · filed 2018-04-24 | $10.50B derived: sum of 4 quarters · filed 2018-04-24 | ||||
| 2017-12-31 | $2.71B 10-K · filed 2018-02-01 | $5.33B derived: sum of 2 quarters · filed 2018-02-01 | $7.97B derived: sum of 3 quarters · filed 2018-02-01 | $10.35B 10-K · filed 2018-02-01 | ||||
| 2017-09-30 | $2.62B 10-K · filed 2018-02-01 | $5.26B derived: sum of 2 quarters · filed 2018-02-01 | $7.64B 10-Q · filed 2017-10-24 | $10.15B derived: sum of 4 quarters · filed 2018-04-24 | ||||
| 2017-06-30 | $2.64B 10-K · filed 2018-02-01 | $5.02B 10-Q · filed 2017-07-25 | $7.52B derived: sum of 3 quarters · filed 2018-04-24 | $10.06B derived: sum of 4 quarters · filed 2018-04-24 | ||||
| 2017-03-31 | $2.38B 10-Q · filed 2018-04-24 | $4.88B derived: sum of 2 quarters · filed 2018-04-24 | $7.42B derived: sum of 3 quarters · filed 2018-04-24 | $9.89B derived: sum of 4 quarters · filed 2018-04-24 | ||||
| 2016-12-31 | $2.50B 10-K · filed 2018-02-01 | $5.04B derived: sum of 2 quarters · filed 2018-02-01 | $7.51B derived: sum of 3 quarters · filed 2018-02-01 | $9.82B 10-K · filed 2018-02-01 | ||||
| 2016-09-30 | $2.54B 10-K · filed 2018-02-01 | $5.01B derived: sum of 2 quarters · filed 2018-02-01 | $7.32B 10-Q · filed 2017-10-24 | $9.74B derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | $2.47B 10-K · filed 2018-02-01 | $4.78B 10-Q · filed 2017-07-25 | $7.20B derived: sum of 3 quarters · filed 2018-02-01 | $9.59B derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | $2.31B 10-K · filed 2018-02-01 | $4.74B derived: sum of 2 quarters · filed 2018-02-01 | $7.13B derived: sum of 3 quarters · filed 2018-02-01 | $9.33B derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | $2.43B 10-K · filed 2017-02-02 | $4.82B derived: sum of 2 quarters · filed 2017-02-02 | $7.02B derived: sum of 3 quarters · filed 2017-02-02 | $9.19B 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | $2.39B 10-K · filed 2017-02-02 | $2.39B 10-Q · filed 2015-10-21 | $4.59B derived: sum of 2 quarters · filed 2017-02-02 | $6.76B 10-Q · filed 2016-10-26 | $6.76B 10-Q · filed 2015-10-21 | $9.05B derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-06-30 | $2.20B 10-K · filed 2017-02-02 | $2.20B 10-Q · filed 2015-07-24 | $4.37B 10-Q · filed 2016-07-21 | $4.37B 10-Q · filed 2015-07-24 | $6.66B derived: sum of 3 quarters · filed 2017-02-02 | $8.78B derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-03-31 | $2.17B 10-K · filed 2017-02-02 | $2.17B 10-Q · filed 2015-04-24 | $4.46B derived: sum of 2 quarters · filed 2017-02-02 | $6.58B derived: sum of 3 quarters · filed 2017-02-02 | $8.63B derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | $2.29B 10-K · filed 2016-02-03 | $4.40B derived: sum of 2 quarters · filed 2016-02-03 | $6.46B derived: sum of 3 quarters · filed 2016-02-03 | $8.20B 10-K · filed 2017-02-02 | $8.20B 10-K · filed 2015-02-04 | |||
| 2014-09-30 | $2.12B 10-K · filed 2016-02-03 | $2.12B 10-Q · filed 2014-10-22 | $4.17B derived: sum of 2 quarters · filed 2016-02-03 | $5.92B 10-Q · filed 2015-10-21 | $7.52B derived: sum of 4 quarters · filed 2016-02-03 | |||
| 2014-06-30 | $2.06B 10-K · filed 2016-02-03 | $2.06B 10-Q · filed 2014-07-23 | $3.80B 10-Q · filed 2015-07-24 | $5.41B derived: sum of 3 quarters · filed 2016-02-03 | $6.86B derived: sum of 4 quarters · filed 2016-02-03 | |||
| 2014-03-31 | $1.74B 10-K · filed 2016-02-03 | $1.74B 10-Q · filed 2014-04-23 | $3.35B derived: sum of 2 quarters · filed 2016-02-03 | $4.80B derived: sum of 3 quarters · filed 2016-02-03 | $6.19B derived: sum of 4 quarters · filed 2016-02-03 | |||
| 2013-12-31 | $1.61B 10-K · filed 2015-02-04 | $3.06B derived: sum of 2 quarters · filed 2015-02-04 | $4.45B derived: sum of 3 quarters · filed 2015-02-04 | $5.54B 10-K · filed 2016-02-03 | $5.54B 10-K · filed 2014-02-06 | |||
| 2013-09-30 | $1.45B 10-K · filed 2015-02-04 | $1.45B 10-Q · filed 2013-10-28 | $2.84B derived: sum of 2 quarters · filed 2015-02-04 | $3.94B 10-Q · filed 2014-10-22 | $5.01B derived: sum of 4 quarters · filed 2015-02-04 | |||
| 2013-06-30 | $1.39B 10-K · filed 2015-02-04 | $1.39B 10-Q · filed 2013-07-25 | $2.48B 10-Q · filed 2014-07-23 | $3.56B derived: sum of 3 quarters · filed 2015-02-04 | $4.60B derived: sum of 4 quarters · filed 2015-02-04 | |||
| 2013-03-31 | $1.10B 10-K · filed 2015-02-04 | $1.10B 10-Q · filed 2013-04-25 | $2.17B derived: sum of 2 quarters · filed 2015-02-04 | $3.21B derived: sum of 3 quarters · filed 2015-02-04 | $4.29B derived: sum of 4 quarters · filed 2015-02-04 | |||
| 2012-12-31 | $1.07B 10-K · filed 2014-02-06 | $2.11B derived: sum of 2 quarters · filed 2014-02-06 | $3.19B derived: sum of 3 quarters · filed 2014-02-06 | $4.17B 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | $1.04B 10-K · filed 2014-02-06 | $1.04B 10-Q · filed 2012-10-25 | $2.12B derived: sum of 2 quarters · filed 2014-02-06 | $3.09B 10-Q · filed 2013-10-28 | $4.09B derived: sum of 4 quarters · filed 2014-02-06 | |||
| 2012-06-30 | $1.08B 10-K · filed 2014-02-06 | $2.05B 10-Q · filed 2013-07-25 | $3.05B derived: sum of 3 quarters · filed 2014-02-06 | $4.02B derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | $975.40M 10-K · filed 2014-02-06 | $975.49M 10-Q · filed 2012-05-01 | $1.97B derived: sum of 2 quarters · filed 2014-02-06 | $2.95B derived: sum of 3 quarters · filed 2014-02-06 | $3.90B derived: sum of 4 quarters · filed 2014-02-06 | |||
| 2011-12-31 | $996.60M 10-K · filed 2013-02-05 | $1.97B derived: sum of 2 quarters · filed 2013-02-05 | $2.93B derived: sum of 3 quarters · filed 2013-02-05 | $3.84B 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | $975.80M 10-K · filed 2013-02-05 | $975.76M 10-Q · filed 2011-10-28 | $1.93B derived: sum of 2 quarters · filed 2013-02-05 | $2.84B 10-Q · filed 2012-10-25 | $3.75B derived: sum of 4 quarters · filed 2013-02-05 | |||
| 2011-06-30 | $956.70M 10-K · filed 2013-02-05 | $956.70M 10-Q · filed 2011-07-26 | $1.86B 10-Q · filed 2012-07-24 | $2.77B derived: sum of 3 quarters · filed 2013-02-05 | $3.65B derived: sum of 4 quarters · filed 2013-02-05 | |||
| 2011-03-31 | $907.10M 10-K · filed 2013-02-05 | $907.10M 10-Q · filed 2011-04-21 | $1.82B derived: sum of 2 quarters · filed 2013-02-05 | $2.69B derived: sum of 3 quarters · filed 2013-02-05 | $3.55B derived: sum of 4 quarters · filed 2013-02-05 | |||
| 2010-12-31 | $909.80M 10-K · filed 2012-02-03 | $1.79B derived: sum of 2 quarters · filed 2012-02-03 | $2.65B derived: sum of 3 quarters · filed 2012-02-03 | $3.47B 10-K · filed 2013-02-05 | ||||
| 2010-09-30 | $876.90M 10-K · filed 2012-02-03 | $876.85M 10-Q · filed 2010-10-26 | $1.74B derived: sum of 2 quarters · filed 2012-02-03 | $2.56B 10-Q · filed 2011-10-28 | $3.39B derived: sum of 4 quarters · filed 2012-02-03 | |||
| 2010-06-30 | $859.20M 10-K · filed 2012-02-03 | $859.24M 10-Q · filed 2010-07-20 | $1.68B 10-Q · filed 2011-07-26 | $2.51B derived: sum of 3 quarters · filed 2012-02-03 | $3.31B derived: sum of 4 quarters · filed 2012-02-03 | |||
| 2010-03-31 | $824.20M 10-K · filed 2012-02-03 | $824.22M 10-Q · filed 2010-04-20 | $1.65B derived: sum of 2 quarters · filed 2012-02-03 | $2.45B derived: sum of 3 quarters · filed 2012-02-03 | $3.24B derived: sum of 4 quarters · filed 2012-02-03 | |||
| 2009-12-31 | $826.80M 10-K · filed 2011-02-04 | $1.63B derived: sum of 2 quarters · filed 2011-02-04 | $2.42B derived: sum of 3 quarters · filed 2011-02-04 | $3.15B 10-K · filed 2012-02-03 | ||||
| 2009-09-30 | $801.70M 10-K · filed 2011-02-04 | $801.69M 10-Q · filed 2009-10-21 | $1.59B derived: sum of 2 quarters · filed 2011-02-04 | $2.33B 10-Q · filed 2010-10-26 | $3.06B derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2009-06-30 | $791.00M 10-K · filed 2011-02-04 | $790.97M 10-Q · filed 2009-07-17 | $1.52B 10-Q · filed 2010-07-20 | $2.26B derived: sum of 3 quarters · filed 2011-02-04 | $3.01B derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2009-03-31 | $733.40M 10-K · filed 2011-02-04 | $733.41M 10-Q · filed 2010-04-20 | $1.47B derived: sum of 2 quarters · filed 2011-02-04 | $2.22B derived: sum of 3 quarters · filed 2011-02-04 | $2.91B derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2008-12-31 | $731.84M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | $1.49B derived: sum of 2 quarters · filed 2011-02-04 | $2.17B derived: sum of 3 quarters · filed 2011-02-04 | $2.84B 10-K · filed 2011-02-04 | ||||
| 2008-09-30 | $758.26M 10-Q · filed 2009-10-21 | $1.44B derived: sum of 2 quarters · filed 2009-10-21 | $2.11B 10-Q · filed 2009-10-21 | |||||
| 2008-06-30 | $684.49M 10-Q · filed 2009-07-17 | $1.35B 10-Q · filed 2009-07-17 | ||||||
| 2007-12-31 | $2.14B 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |